ANRO: Alto Neuroscience Company Aggregate Debts

Symbol and logo of brand Alto Neuroscience Inc (ANRO)

Alto Neuroscience, Inc. (ANRO) develops personalized psychiatric treatments in the US utilizing AI-driven brain analysis. The leverage ratio on GURU.Markets provides real-time dynamics of liabilities, where the indicator remains around 0.03. Asset value growth is driven by breakthroughs in depression treatment and M&A potential, while the company strictly adheres to biochemical waste disposal regulations.

ANRO: Alto Neuroscience, Inc. Company Debts 02/21/2024 - 10/29/2026

Alto Neuroscience (ANRO) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart Alto Neuroscience Corp|ANRO - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Alto Neuro|ANRO - Total Company Value
- balance sheet equity data:
Accounting Value of a Share Alto Neuroscience|ANRO - Company Book Value|Market Cap to Net Assets Ratio altoneuroscience.com|ANRO - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Alto Neuroscience, Inc.|ANRO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Alto Neuroscience Inc|ANRO - Company Debts|Debts to Book Capitalization Ratio Alto Neuro|ANRO - Company Long-Term Debt|Short-Term Debt Volume Alto Neuroscience|Immediate Liquidity altoneuroscience.com
- earnings and valuation multiples information:
ANRO - Net Profit
Fundamental company analysis:Alto Neuroscience Corp - ANRO
Signature product of Alto Neuroscience Inc

This indicator aggregates all loan and bond obligations, allowing for a real-time assessment of the company's financial autonomy without reporting delays. By analyzing the business's debt dynamics, an investor can determine if Alto Neuroscience, Inc. (ANRO) possesses sufficient resources to protect its AI-psychiatry patents and compete with industry behemoths without excessive credit dependence.

Competitors of Alto Neuroscience, Inc.

ALKS (Alkermes Corp) - Aggregate Debt Obligations|Company Aggregate Debts AVDL (Avadel Pharmaceuticals)|Company Aggregate Debts atai.life ATAI|GHRS - Company Debts|Aggregate Debt Obligations MNMD (Mind Medicine (MindMed) Inc.)|Compass Pathways (CMPS) - Company Debts|Company Total Debt LB Corp|DRUG (Bright Minds Biosciences) - Company Aggregate Debts|Company Aggregate Debts vandapharma.com|Company Total Debt CYBN (Cybin Inc.)|NRXP (NRx Pharmaceuticals Inc.) - Aggregate Debt Obligations|Company Debts Cingulate CING|SILO (Silo Pharma Inc.) - Company Aggregate Indebtedness|CPHI - Company Debts|Company Total Debt Obligations clearmindmedicine.com CMND|PBM (Psyence Biomedical) - Company Total Debt|Company Cumulative Debt SciSparc Ltd. (SPRC)|SEEL (Seelos Therapeutics, Inc) - Company Aggregate Debts|Company Total Debt Virpax (VRPX)|Company Aggregate Debts KRTX